Building the Oncology System of the Future:

C ANCER C ENTER B USINESS S UMMIT
Building the
Oncology
System of
the Future:
Transforming Patient Care
Through Data Transparency
and Analytics
November 6 -7, 2014
Fairmont Chicago, Millennium Park
Chicago, Illinois
CancerBusinessSummit.com
A focus on the Future State of Cancer Care Delivery Featuring Plenary Sessions On:
Building the Oncology System of the Future
The Future of Oncology Reimbursement:
Alternate Payment Initiatives
Oncology’s Fit in the
Healthcare Sector
The Medicare Perspective:
CMMI-Oncology Care Model
KEYNOTE ADDRESS By
Paul H. Keckley, Ph.d.
Vision of the Future from the
Oncologist’s Vantage Point
Allen S. Lichter,M.D., FASCO
Kavita Patel, M.D., MS
The Health Plan
Perspective
Michael Kolodziej, M.D.
SUMMIT SPONSORS
21st Century Oncology • ADVI • Alliance Oncology • Altegra Health • Appistry, Inc. • Cancer Treatment Centers of America
Castle Connolly • ECG Management Consultants, Inc. • EH Strategies • Harborside Press LLC • HealthCare Appraisers, Inc. • InformedDNA
INTEGRATED Healthcare Strategies • Lilly Oncology • Millennium Pharmaceuticals: The Takeda Oncology Company • MolecularHealth
N-of-One, Inc. • nanoString Technologies • Navigating Cancer • New Century Health • Onco360 Oncology Pharmacy • Oncology Business Review
Oncology Management Consulting Group • Oncology Resource Consultants, Inc. • Oncology Services International • Oncology Solutions, LLC
Oncology Supply/ION Solutions • PYA • Personalized Medicine Coalition • Revenue Cycle, Inc. • The Schwartz Center for Compassionate Healthcare • Via Oncology
WELCOME TO THE
2014 CANCER CENTER
BUSINESS SUMMIT
WELCOME
We welcome you to the 2014 Cancer Center Business Summit. The theme of the 2014 Summit is Building the Oncology System of the
Future: Transforming Patient Care Through Data Transparency and Analytics.
Virtually everyone agrees that the time is now to seriously reexamine our fragmented, expensive healthcare system and to innovate
sustainable approaches to curing its ills. At the center of this activity is the patient, as the ultimate consumer of health care services. Until
recently, patients largely have been shielded from health care costs by health insurance and governmental payment programs with low
copays/deductibles or first dollar indemnity coverage. Patients have also been relatively unaware of quality differentials because of the
lack of standard reporting on meaningful quality measures.
Today, as a result of governmental and private market “transparency” initiatives, an increasing amount of quality and cost information
is becoming available to the public; and patients have greater incentives to make cost effective choices about their preferred site and
providers of oncology care. One of the new dynamics driving oncology consumerism is new health insurance product designs that involve
higher patient co-pays for more expensive care options and limited, tiered and exclusive provider networks. Site of service differentials
and provider-based co-pays are also impacting patient choices. Also driving oncology consumerism is increased activism by employer
self-funded plans that are offering healthy lifestyle incentives and, in some cases, disincentives for unhealthy behaviors. Oncology
consumerism is further emboldened by disruptive information and medical technologies that give patients enhanced self-care capability,
with access to a trove of health information. These include electronic health monitoring and internet or home based support services,
including specialty pharmaceuticals.
While the “science” of quality and value measurement is in its infancy, some innovative oncology organizations are collecting and analyzing
reams of potentially actionable data. These data analytics are an engine of evidence-based change for the benefit of consumers—but in
directions that are not always intuitively obvious or welcomed by the status quo.
During this time of disruptive change, cancer care providers are understandably concerned about reimbursement reductions; about
being excluded from payer contracting networks; about patient incentives to use less expensive providers; about losing referral sources
as primary care physicians and other specialists align with specific networks; about the pressure to give up practice autonomy and
become employees of hospitals or large multi-specialty groups; about the impact of new value-based, alternative payment arrangements
(like shared savings, bundled payment, episode of care, and capitation arrangements); about the impact of ACOs, medical homes and
other clinically integrated care organizations; and about the trend toward industry consolidation that threatens their professional autonomy.
In this new consumerist and cost conscious health care environment, there are critical questions to be answered about what innovative
strategies and solutions are available to community oncology providers to survive and thrive.
At the Summit, you will have the rare opportunity to learn from industry leaders and your peers about the changes occurring in the cancer
care marketplace and how cancer care organizations are responding to them. The Summit faculty consists of experienced cancer care
executives, physician leaders, and leaders from the financial, business, payor, and legal communities. Their diverse perspectives provide
a unique synthesis of the most important issues facing cancer care providers today.
As we begin the 2014 Summit, we give hearty thanks to all of our wonderful faculty members, advisors, and sponsors who have given
generously of their time, talent, and resources to make this year’s Summit a success. We also thank you for attending and adding your
voice to this unique and timely discussion. It is our honor to host you. We hope that you will enjoy the Summit, forge new relationships,
and learn practical tips to help build a durable and sustainable oncology system of the future.
Thank you,
2014 Cancer Center Business Summit Hosts
www.CancerBusinessSummit.com
1
The firm worth
listening to
is the firm that
listens to you.
SM
Talk to Foley. We’re listening.
SM
Our health care clients tell us they want
counsel who help them manage the
sweeping challenges they face … and
we’re listening. In 2014, Foley was
named U.S. News – Best Lawyers® “Law
Firm of the Year — Health Care Law”
for the third consecutive year.
Tell us how Foley can help you manage your health
care matters. Contact Partner Michael L. Blau in
our Boston office at [email protected]
Foley.com
BOSTON • BRUSSELS • CHICAGO • DETROIT • JACKSONVILLE • LOS ANGELES • MADISON
MIAMI • MILWAUKEE • NEW YORK • ORLANDO • SACRAMENTO • SAN DIEGO • SAN FRANCISCO
SHANGHAI • SILICON VALLEY • TALLAHASSEE • TAMPA • TOKYO • WASHINGTON, D.C.
©2014 Foley & Lardner LLP • Attorney Advertisement • Prior results do not guarantee a similar outcome • 321 N. Clark Street, Suite 2800, Chicago, IL 60654 • 312.832.4500 • 14.10642
2014 SUMMIT SPONSORS
PLATINUM SPONSORS
21st Century Oncology
Millennium Pharmaceuticals: The Takeda Oncology Company
GOLD SPONSORS
Alliance Oncology
Altegra Health
Cancer Treatment Centers of America
HealthCare Appraisers, Inc.
MolecularHealth
Onco360 Oncology Pharmacy
Via Oncology
SILVER SPONSORS
ADVI
Castle Connolly
Lilly Oncology
nanoString Technologies
Oncology Management Consulting Group
Oncology Resource Consultants, Inc.
Oncology Supply/ION Solutions
PYA
BRONZE SPONSORS
Appistry, Inc.
ECG Management Consultants, Inc.
Harborside Press LLC
InformedDNA
INTEGRATED Healthcare Strategies
Navigating Cancer
N-of-One, Inc.
New Century Health
Oncology Solutions, LLC
Revenue Cycle, Inc.
IN-KIND SPONSORS
Oncology Business Review
Personalized Medicine Coalition
The Schwartz Center for Compassionate Healthcare
ATTENDEE LIST SPONSOR
Alliance Oncology
LANYARD SPONSOR
Oncology Services International
www.CancerBusinessSummit.com
3
Oncology-Specific EMR
Cancer Practice Analytics
certified & cloud-based
Visit Altos Solutions, Inc.
• Cancer Center Business Summit
Altos Social Media
AltosSolutions.com
888-662-6367 Ext 2
REGISTRATION & MEETING ROOMS
All meetings and events will be held at the Fairmont Chicago,
Millennium Park Hotel. Summit representatives will be available
should you have any questions or special needs.
The registration desk will be open on Wednesday, November 5, 2014
from 5:00 p.m. to 8:00 p.m.
On Thursday, November 6, 2014, registration will begin at 7:00 a.m.
and the program sessions will commence at 8:00 a.m. In addition,
there will be a networking luncheon from 12:00 p.m. to 1:00 p.m.
The day will conclude with a networking reception immediately
following the Summit Wrap-Up.
On Friday, November 7, 2014, registration will be open from
6:30 a.m. to 11:00 a.m. Sunrise Session will begin at 7:00 a.m.
followed by two tracks of breakout sessions at 8:00 a.m. and
conclude at 12:30 p.m.
A Networking Continental Breakfast will be provided both days.
While in meeting rooms, please silence all cell phones and
pagers. Additionally, we ask that you refrain from using all A/V
recording devices.
2014 ADVISORY BOARD
Edward Abrahams, Ph.D.,
Personalized Medicine Coalition
Teri U. Guidi, MBA, FAAMA
Oncology Management Consulting Group
Michael J. Anderson, M.D.
Dana-Farber Community Cancer Care
Richard J. Hall
Oncology Services International
Ronald Barkley, M.S., J.D.
Cancer Center Business Development Group
John E. Hennessy, MBA, CMPE
Sarah Cannon Cancer Services
Thomas R. Barr, MBA
Oncology Metrics®, a division of Flatiron
Health, Inc.
Cory Jones, MBA
Catholic Health Initiatives
David C. Beyer, M.D., FACR, FACRO,
FASTRO
Arizona Oncology Services
Michael L. Blau, J.D.
Foley & Lardner LLP
Linda Bosserman, M.D., FACP
City of Hope
Lindsay Conway, MSEd
The Advisory Board Company
John V. Cox, D.O., MBA, FASCO
American Society of Clinical Oncology®
Bruce Cutter, M.D., MMM
Group Health Cooperative
William Jordan, D.O.
The Center for Cancer and Blood Disorders
Deborah Kamin, Ph.D.
American Society of Clinical Oncology®
Ira Klein, M.D., MBA, FACP
Aetna
Michael Kolodziej, M.D.
Aetna
Mark Krasna, M.D.
Meridian Health Systems
Peter Kuhn, Ph.D.
University of Southern California
Barbara L. McAneny, M.D.
New Mexico Oncology Hematology
Consultants, Ltd.
Gitesh Patel
Sargas Pharmaceutical Adherence &
Compliance (SPAC) International
R. Steven Paulson, M.D.
Texas Oncology, PA
Barry Russo, MBA
The Center for Cancer and Blood Disorders
Kelley D. Simpson
Oncology Solutions, LLC
Mark Sobczak, M.D.
Fox Chase Cancer Center
John Steiner, Esq.
Cancer Treatment Centers of America
Timothy J. Thompson
Intervention Insights
Elaine L. Towle, CMPE
Oncology Metrics®, a division of Flatiron
Health, Inc.
Kathleen G. Lokay
Via Oncology
Daniel Dosoretz, M.D.
21st Century Oncology
www.CancerBusinessSummit.com
5
CCBD
GROUP
CANCER CENTER BUSINESS DEVELOPMENT
The Future State
of Cancer Care Delivery . . . .
Tra n s i t i o n i n g oncology stakeholder s
f ro m here to there
 Practice mergers, strategic growth initiatives
and partnering options
 Oncologist-hospital alignment transactions: professional
and management services agreements (PSA, MSA), service
line consolidation and co-management
 Alternate payment methodologies: CMMI-Oncology Care
Model (OCM) program design, value based fee structures,
shared savings, bundled pricing
w w w.cc b d group.com
603.472.2285
SUMMIT AGENDA
Wednesday, November 5, 2014
5:00 p.m. - 8:00 p.m.
Registration
INTERNATIONAL BALLROOM FOYER AREA
(SECOND LEVEL)
Thursday, November 6, 2014
7:00 a.m. - 5:30 p.m.
Registration
7:00 a.m. - 7:50 a.m.
Networking Continental Breakfast
8:00 a.m. - 8:15 a.m.
Introduction and Opening Remarks
8:15 a.m. - 9:45 a.m. Building the Oncology System of the Future
9:45 a.m. - 10:00 a.m. Networking Break
10:00 a.m. - 12:00 p.m. The Future of Oncology Reimbursement: Alternate Payment Initiatives
Networking Luncheon
Patient Engagement: Key to Better Outcomes?
Networking Break
Actionable Data Analytics: Past, Present, Future
Networking Break
The Role of Personalized Medicine
in our Future Delivery System
Day 1 Closing Remarks
Networking Reception
12:00 p.m. - 1:00 p.m.
1:15 p.m. - 2:15 p.m.
2:15 p.m. – 2:30 p.m.
2:30 p.m. – 3:30 p.m.
3:30 p.m. – 3:45 p.m.
3:45 p.m. – 5:00 p.m.
5:00 p.m. - 5:15 p.m.
Immediately Following
INTERNATIONAL BALLROOM FOYER AREA
(SECOND LEVEL)
IMPERIAL BALLROOM (B2 LEVEL)
INTERNATIONAL BALLROOM (SECOND LEVEL)
INTERNATIONAL BALLROOM (SECOND LEVEL)
IMPERIAL BALLROOM (B2 LEVEL)
INTERNATIONAL BALLROOM (SECOND LEVEL)
IMPERIAL BALLROOM (B2 LEVEL)
INTERNATIONAL BALLROOM (SECOND LEVEL)
IMPERIAL BALLROOM (B2 LEVEL)
INTERNATIONAL BALLROOM (SECOND LEVEL)
IMPERIAL BALLROOM (B2 LEVEL)
INTERNATIONAL BALLROOM (SECOND LEVEL)
INTERNATIONAL BALLROOM (SECOND LEVEL)
IMPERIAL BALLROOM (B2 LEVEL)
Friday, November 7, 2014
6:30 a.m. - 7:50 a.m.
Networking Continental Breakfast
7:00 a.m. – 11:00 a.m.
Registration
INTERNATIONAL BALLROOM (SECOND LEVEL)
IMPERIAL BALLROOM (B2 LEVEL)
INTERNATIONAL BALLROOM FOYER AREA (SECOND LEVEL)
GOLD ROOM (SECOND LEVEL)
7:00 a.m. – 7:55 a.m.
TRACK A
Sunrise Session: Valuing Oncology
Transactions
8:00 a.m. – 9:00 a.m.
TRACK A
Site-of Service Cost Differential Debate and
340B Update
In-Office Pharmacy:
Should Every Practice Have One?
9:10 a.m. – 10:10 a.m.
TRACK A
Alternate Payment Methodologies in Oncology:
Building & Costing Care Bundles
TRACK B
Benchmarking: If You Can’t Measure It,
You Can’t Manage It.
10:20 a.m. – 11:20 a.m.
TRACK A
Oncologist-Hospital Alignment: Framing and
Transacting the Relationship
TRACK B
Future of Drug Formulary & Delivery
11:30 a.m. – 12:30 p.m.
TRACK A
Oncologist-Hospital Alignment: Implementing
the Relationship
TRACK B
Showcase of ASCO-JOP Case Studies
12:30 p.m.
Summit Adjourns
TRACK B
Sunrise Session: Evolving the Oncology
Medical Home
TRACK B
7
Imagine if your practice could see
patients a day.
When trial data inform our decisions, we tap into only 3% of the cancer patient population.
CancerLinQ™ will let you learn from the other 97%.
Designed by cancer experts. The cancer experts at the
ASCO Institute for Quality™ are assembling vast amounts
of usable, searchable, real-world cancer information into a
powerful database that promises to transform nearly every
aspect of cancer care.
Learn more at asco.org/cancerlinq
To elevate your practice. Imagine searching and seeing
trends among millions of patients with almost every
treatment, tumor type, and genomics. Those big numbers
will help inform the care of your patients—every single one.
And that’s a number to be proud of.
WEDNESDAY, NOVEMBER 5, 2014
5:00 p.m. - 8:00 p.m.
INTERNATIONAL BALLROOM FOYER AREA (SECOND LEVEL)
Registration
THURSDAY, NOVEMBER 6, 2014
7:00 a.m. - 5:30 p.m.
INTERNATIONAL BALLROOM FOYER AREA (SECOND LEVEL)
Registration
7:00 a.m. - 7:50 a.m.
IMPERIAL BALLROOM (B2 LEVEL)
Networking Continental Breakfast
8:00 a.m. - 8:15 a.m.
INTERNATIONAL BALLROOM (SECOND LEVEL)
Introduction and Opening Remarks
Michael L. Blau, J.D., Chair, Industry Teams, Partner, Foley & Lardner LLP
8:15 a.m. – 9:45 a.m.
Building the Oncology System of the Future Keynote Address:
Paul H. Keckley, Ph.D., Managing Director, Navigant Center for Healthcare Research & Policy Analysis
Allen S. Lichter, M.D., FASCO, Chief Executive Officer, American Society of Clinical Oncology®
Lindsay Conway, MSEd, Practice Manager, Oncology Roundtable, The Advisory Board Company
Gary H. Lyman, M.D., MPH, Co-Director, Fred Hutchison Institute for Cancer Outcomes Research
The convergence of market consolidation, coverage expansion, cost shifting, alternate payment initiatives and scientific
advances in the treatment of cancer are forcing oncology providers to re-invent their fundamental business and care delivery
models. Panelists will examine the implications of this systemic transformation from the following perspectives:
• The healthcare sector as a whole
• The oncology profession
• The community hospital-based cancer program
• The academic medical center cancer program
In this session the challenges and opportunities created by this systemic transformation will be explored and a consensus
vision for the future state of cancer care delivery will be offered.
9:45 a.m. – 10:00 a.m.
IMPERIAL BALLROOM (B2 LEVEL)
Networking Break
www.CancerBusinessSummit.com
9
Image: Colored scanning electron micrograph
(SEM) of a lymphoma cancer cell.
One goal: a shared commitment to improve
the lives of cancer patients everywhere.
Millennium: The Takeda Oncology Company carries an extensive pipeline — among the
top in oncology worldwide — with more than 15 compounds in development for a broad
range of solid and hematological cancers.
We are dedicated to building strong partnerships with the oncology community.
Together we can make a dramatic impact on cancer therapeutics over the next decade.
To learn more, visit us at millennium.com.
©2014 Millennium Pharmaceuticals, Inc. All rights reserved.
THURSDAY, NOVEMBER 6, 2014 (Continued)
10:00 a.m. – 12:00 p.m.
INTERNATIONAL BALLROOM (SECOND LEVEL)
The Future of Oncology Reimbursement: Alternate Payment Initiatives
Moderator:
Marc Samuels, J.D., M.P.H., Chief Executive Officer, ADVI
Panelists:
Michael Kolodziej, M.D., National Medical Director, Oncology Solutions, Aetna
Kavita Patel, M.D., MS, Fellow and Managing Director for Clinical Transformation & Delivery, Engelberg Center Health Care
Reform, The Brookings Institution
Denise K. Pierce, President and Chief Executive Officer, DK Pierce & Associates, Inc.
Larry Strieff, M.D., Specialty Medical Director, Hill Physicians Medical Group
Robin T. Zon, M.D., FACP, Michiana Hematology Oncology & Clinical Practice Committee, American Society of Clinical Oncology®
BREAKING NEWS: Interest Surges in Medicare Bundled Payment Initiative. Modern Healthcare. July 31, 2014. Much of
the activity to date in bundled payment has been associated with the Medicare Bundled Payments for Care Improvement
(BPCI) initiative, which has consisted principally of cardiac and orthopedic procedures with a hospital inpatient component.
But, could oncology be next in line for transformation to bundled pricing or some other form of alternate payment? In this
session, panelists will explore from differing perspectives the current major initiatives in oncology alternate payment. What
programs are in place now, what are their objectives and what has been their experience?
• Medicare: The CMMI Oncology Care Model (OCM)
• Oncology alternate payment from a national health plan perspective
• ASCO’s Consolidated Payment for Oncology Care (CPOC)
• Oncology Case Rates in an advanced managed care setting
• Do employers have an opinion about alternate payment for employee cancer care?
12:00 p.m. – 1:00 p.m.
IMPERIAL BALLROOM (B2 LEVEL)
Networking Luncheon Presentation of the Annual Foley & Lardner LLP Cancer Center Innovator Award
1:15 p.m. – 2:15 p.m.
INTERNATIONAL BALLROOM (SECOND LEVEL)
Patient Engagement: Key to Better Outcomes?
Diane Blum, MSW, FASCO, Former Chief Executive Officer, Lymphoma Research Foundation
Linda D. Bosserman, M.D., FACP, Assistant Clinical Professor, City of Hope
Gena Cook, Co-Founder and Chief Executive Officer, Navigating Cancer
Julie Rosen, MMHS, Executive Director, Schwartz Center for Compassionate Healthcare
Studies prove that patients who are activated and engaged in their care achieve better outcomes at lower costs with higher
rates of satisfaction. As such, there are new requirements for providers to establish a more comprehensive relationship with
their patients and provide more services to support patient centered care. In this session, the panelists will discuss real
world strategies and challenges to engaging patients and in providing patient centered oncology care including:
• The new requirements and how new payment models need to evolve
• The challenges of engaging patients and the differences between different patient segments
• The landscape of available tools and the need for a more coordinated approach to effectively deliver new services
2:15 p.m. – 2:30 p.m.
IMPERIAL BALLROOM (B2 LEVEL)
Networking Break
www.CancerBusinessSummit.com
11
Personalized Treatment for
the Fight Against Cancer
Cancer Treatment Centers of America® (CTCA), is the proud sponsor of the Cancer Center
Business Summit. At CTCA® we believe that health care is always and only about the
patient. That’s why we provide comprehensive, fully-integrated cancer care, all under
one roof. Every patient receives a personalized approach, which puts them at the center
of their treatment decisions.
We call it Patient Empowered Care®, and we’re proud to be leading the charge toward
truly personalized medicine.
cancercenter.com
cancercenter.com
Atlanta
Chicago
Philadelphia
©2014 Rising Tide
Phoenix
Tulsa
THURSDAY, NOVEMBER 6, 2014 (Continued)
2:30 p.m. – 3:30 p.m.
INTERNATIONAL BALLROOM (SECOND LEVEL)
Actionable Data Analytics: Past, Present, Future
Moderator:
Thomas R. Barr, MBA, General Manager, Oncology Metrics®, a division of Flatiron Health, Inc.
Panelists:
Brian S. Gorin, Managing Principal, Analysis Group, Inc.
Peter Kuhn, Ph.D., Dean’s Professor of Biological Sciences, University of Southern California Dornsife
Richard L. Schilsky, M.D., FACP, FASCO, Chief Medical Officer, American Society of Clinical Oncology®
Eric Schuur, Ph.D., Principal, VMWA LLC and Associate, The Jon Block Group
It has become painfully obvious that today’s data infrastructure is inadequate to support the needs of the healthcare sector. It is widely
accepted that the future state of healthcare delivery will, or at least should, be anchored in objective evidence gained in real time from
everyday clinical experience. The potential for clinical and economic benefit of data analytics is particularly compelling in oncology,
with the advances in medical science, particularly the new drug pipeline and the advent of the “omics” (genomics, proteomics).
What is the business environment for development of new data and what progress has occurred so far? What actionable analytics are
available right now – today, and what are the aspirational potentials of massive data analysis? Topics addressed include:
• The concept of “actionable” data analytics
• The economic and regulatory system hurdles that new diagnostics must overcome to make new data possible
• Past approaches using circulating tumor cell technology development to reveal an economic “death valley,”
where good science can become lost
• Case study of the present capabilities of data aggregation and analysis to inform clinical decision making
• A future that realizes the aspirational goal of massive data interrogation leading to the discovery and
incorporation of subclinical and/or the presently unseen into the process of oncology care design.
3:30 p.m. – 3:45 p.m.
IMPERIAL BALLROOM (B2 LEVEL)
Networking Break
3:45 p.m. – 5:00 p.m.
INTERNATIONAL BALLROOM (SECOND LEVEL)
The Role of Personalized Medicine in our Future Delivery System
Moderator:
Edward Abrahams, Ph.D., President, Personalized Medicine Coalition
Panelists:
Christine Cournoyer, Chief Executive Officer, N-of-One
Maurie Markman, M.D., Senior Vice President for Clinical Affairs, Cancer Treatment Centers of America
Catherine A. McCarty, Ph.D., MPH, Principal Research Scientist, Essentia Health
Rebecca Sutphen, M.D., FACMG, President and Chief Medical Officer, InformedDNA
Timothy Thompson, Chief Executive Officer, Intervention Insights
This panel will explore the integration of personalized approaches to cancer care into the health care system from multiple
points of reference, and include discussion of the public policies that could encourage or impede its development.
5:00 p.m. –5:15 p.m.
INTERNATIONAL BALLROOM (SECOND LEVEL)
Day 1 Closing Remarks
John V. Cox, D.O., MBA, FASCO, Texas Oncology, PA, Editor, Journal of Oncology Practice
Immediately Following
IMPERIAL BALLROOM (B2 LEVEL)
Networking Reception
13
Reach your full potential.
Alliance Oncology Offers:
Unmatched Expertise …
An industry leader in radiation therapy & innovative oncology programs.
Access to State-of-the-Art Technology …
Continuous investment to adopt new technologies and clinical protocols.
Comprehensive, Customized Solutions …
From planning to patient care and everything in between.
World-Class Operations …
For our radiosurgery centers, average case volume is 80% higher than typical centers.
Network of Excellence (Resources) …
We put the best to work for you, physicians, physicists, therapists, nurses, administrators, and operations.
Superior Patient Care & Satisfaction …
Winner of Avatar’s Exceeding Patient Expectations Award (top 5%) for 7 years in a row.
Dynamic, Focused Marketing …
We average 42% of patients drawn from outside the hospital’s primary service area.
Financial Backing for Equipment…
Full capital outlay and non-recourse financing.
Contact us today to reach the full potential of your oncology service line.
[email protected] or 615-263-7888
1801 West End Avenue, Suite 700, Nashville, TN 37203
FRIDAY, NOVEMBER 7, 2014
6:30 a.m. - 7:50 a.m.
IMPERIAL BALLROOM (B2 LEVEL)
Networking Continental Breakfast
7:00 a.m. - 11:00 a.m.
INTERNATIONAL BALLROOM FOYER AREA (SECOND LEVEL)
Registration
7:00 a.m. - 7:55 a.m.
Track A
Track B
INTERNATIONAL BALLROOM (SECOND LEVEL)
GOLD ROOM (SECOND LEVEL)
Sunrise Session: Valuing Oncology Transactions
Sunrise Session: Evolving the Oncology
Medical Home
Moderator:
Alan H. Einhorn, J.D., Of Counsel, Foley & Lardner LLP
Panelists:
Daryl P. Johnson, MAcc, CVA, Managing Partner, HealthCare
Appraisers, Inc.
Tony Kouba, MS, MHA, Vice President, INTEGRATED
Healthcare Strategies
W. James Lloyd, CPA/ABV, ASA, CFE, Principal, PYA
Jeff Sinaiko, Founding Principal/Special Advisor, Altegra Health
Those who attend this session will learn why obtaining a
credible valuation opinion is critical to their oncology
transactions, and they will leave the session with valuable
insights into--and tips on addressing-- the hottest valuation
topics now affecting oncology arrangements. Topics will
include: when and how much can oncologists be paid for
supervision of infusion services? How is 340B drug pricing
accessed and how can it add value for oncologists? What
are the special issues relating to pharmacies? What are the
fundamentals of, and current trends in, PSA models and
co-management agreements (and what are their pros and
cons)? What other arrangements/revenue streams are out
there and what valuation issues do they raise? What are the
key areas of regulatory risk where parties to these transactions should tread carefully?
Our panelists will also provide insight on the different
ways that valuation consultants are engaged and how the
parties to a transaction can most effectively participate in
the valuation process. Active interaction with our panelists
is encouraged.
www.CancerBusinessSummit.com
Ira M. Klein, M.D., MBA, FACP, National Medical Director,
Clinical Thought Leadership, Office of the Chief Medical
Officer, Aetna
Michael Kolodziej, M.D., National Medical Director Oncology
Solutions, Aetna
Kathleen G. Lokay, President and Chief Executive Officer,
Via Oncology
Barry Russo, MBA, Chief Executive Officer, The Center for
Cancer and Blood Disorders
Maria Sipala, Director, Strategic Planning, National Network
Contracting Strategies, Aetna
Amy Supraner, Strategic Planning Manager, National Network
Contracting Strategies, Aetna
The Oncology Medical Home has been held up as an
example of promise and peril in this age of oncology
medical payment reform. The Aetna contracting and
clinical team have been through several generations of
pilot programs across the U.S., and are now building a
durable and holistic oncology medical home construct
for national rollout. This presentation and panel discussion will present their experiences with building on
evidence, marrying clinical and administrative data,
and creating metrics and shared savings arrangements
that make sense for both quality improvement and cost
control for practices, payers, and most importantly,
for patients. The underlying premise is that this
current model for creating an oncology medical home
will allow community oncology practices to thrive with
unparalleled patient care under changing payment
methodologies, and at the same time, demonstrate their
value when compared with other delivery models in a
market or region.
15
Altegra Health / Solutions
Reimbursement & Advisory Services
The experience
to get results.
The integrity
to do things right.
For more than 20 years, we have been a trusted advisor to the
nation’s most prominent healthcare organizations and health
law practices. Let us put our experience to work for you.
OUR SERVICES
Coding & Reimbursement
ICD-10 Solutions
Compliance & Internal Audit
Valuation & Transactions
Revenue Cycle & Healthcare IT
Litigation Support
Strategic Analytics
AltegraHealth.com/RAS
Office: 310.776.4500
Email: [email protected]
Learn More
Visit:
FRIDAY, NOVEMBER 7, 2014 (Continued)
Breakout Sessions
8:00 a.m. -9:00 a.m.
Track A
Track B
INTERNATIONAL BALLROOM (SECOND LEVEL)
GOLD ROOM (SECOND LEVEL)
Site-of-Service Cost Differential Debate and
340B Update
In-Office Pharmacy:
Should Every Practice Have One?
Elizabeth S. Elson, Of Counsel, Foley & Lardner LLP
Gitesh Patel, Chief Executive Officer, Sargas Pharmaceutical
Adherence and Compliance International
Matthew Farber, MA, Director, Provider Economics and
Public Policy, Association of Community Cancer Centers
John Hennessy, MBA, Vice President, Operations,
Sarah Cannon Cancer Services
Erich Mounce, MHA Chief Executive Officer, The West Clinic
Bruce S. Pyenson, FSA, MAAA, Principal and Consulting
Actuary, Milliman
Dan Todd, Former Health Policy Advisor,
Senate Finance Committee
As more medical oncology practices have migrated from a
physician office setting to a hospital setting, payors have
reported cost increase related to those moves. At the
same time Medicare fee schedules for radiation oncology
practices have been shrinking relative to hospital based
settings. And the 340B program has seen volume growth
as the shift of sites of service has accelerated.
The panel will focus on the data identifying site of service
differentials, and discuss government and market reactions
to the site of service shift. There will also be a discussion
of legal issues and potential changes to the 340B program.
We will discuss both sustainability of the differential and
how we may see it change over the next few years.
www.CancerBusinessSummit.com
Jeff Patton, M.D., Chief Executive Officer Tennessee Oncology,
Chief Medical Officer Rain Tree Oncology Services
Barry Russo, MBA, Chief Executive Officer, The Center for
Cancer and Blood Disorders
The shift in chemotherapy drug product from intravenous
to oral form continues at record pace. Today, some 25%
to 30% of drug revenue that was previously associated
with intravenous drug administration in the community
oncology practice setting is now subject to an oral drug
alternative. And given the pharmaceutical development
“pipeline” of orals, the impact on community practice
revenues is expected to climb to 35% to 40% in the
near term. What should community oncologists do
in light of this dynamic? Is an in-office dispensing
pharmacy a viable option? Do specialty pharmacies
have a role? What impact can be expected from
“closed end hubs?” Panelists will explore the challenges
and implications of this paradigm to patient care,
patient experience, patient adherence and practice
financial viability.
17
FRIDAY, NOVEMBER 7, 2014 (Continued)
Breakout Sessions
9:10 a.m. - 10:10 a.m
Track A
Track B
INTERNATIONAL BALLROOM (SECOND LEVEL)
GOLD ROOM (SECOND LEVEL)
Alternate Payment Methodologies in Oncology:
Building and Costing Care Bundles
Benchmarking: If You Can’t Measure It, You
Can’t Manage It.
Constantine A. Mantz, M.D., Chief Medical Officer,
21st Century Oncology
Teri U. Guidi, MBA, FAAMA, President and Chief Executive Officer,
Oncology Management Consulting Group
Therese Mulvey, M.D., Physician-in-Chief/Medical Oncology,
SouthCoast Health System
Elaine L. Towle, CMPE, Director, Consulting Services Oncology
Metrics®, a division of Flatiron Health, Inc.
Khanh Nguyen, Pharm.D., Director, Clinical Support
Hill Physicians Medical Group
Mark L. Sobczak, M.D., Chief Network Officer and Senior Vice
President, Fox Chase Cancer Center
John E. Steiner, Esq., Chief Compliance & Privacy Officer &
Associate General Counsel, Cancer Treatment Centers of America
Bundles, episodes, and case rates. What has been the
experience with pricing oncology care under such fixed
rate methodologies? What is the scope of services included in these bundles? Have these pricing programs had
an influence in physician ordering patterns or resource
consumption? What have been the effects of these
programs on the patient experience? Finally, have
these programs reduced the overall cancer spend in
any discernible way?
This session will present and discuss the results from
two recent industry surveys: the 2014 National Practice
Benchmark and the 2014 National Hospital Oncology
Benchmark Study. Discussion will focus on using benchmarks to manage today’s oncology service. Participants
will be provided with benchmarks to immediately apply
to their own oncology practice setting.
The panelists will address these and more questions
from the their experience with alternative payment methodologies in the initial consultation/formulation of a plan
of care, in the comprehensive treatment of lung cancer,
in the delivery of radiation therapy across multiple
malignancies, and in the case rates for a broad range
of cancers treated by the oncology provides within a
large scale multispecialty medical group/IPA.
www.CancerBusinessSummit.com
19
CANCER
MANAGEMENT IS
xELPMOC...
THE ONCOLOGY
PHARMACY
SOLUTION IS SIMPLE.
OncoMed Pharmacy / 877.662.6633
OncoMed Pharmacy Fax / 877.662.6355
Website / Onco360.com
OncoMed is JCAHO-Accredited
& the Dispensing Pharmacy of Onco360
Providing solutions for:
Patients | Oncologists | Manufacturers | Health Plans | Employers | PBMs | Hospitals
FRIDAY, NOVEMBER 7, 2014 (Continued)
Breakout Sessions
10:20 a.m. - 11:20 a.m.
Track A
Track B
INTERNATIONAL BALLROOM (SECOND LEVEL)
GOLD ROOM (SECOND LEVEL)
Oncologist-Hospital Alignment: Framing and
Transacting the Relationship
Future of Drug Delivery and Formulary
Michael L. Blau, J.D., Chair, Industry Teams, Partner,
Foley & Lardner LLP
Scott Herbert, M.D., President, New Mexico Cancer Care
Melissa Grimes Ayles, Director of Partner Relations & Business
Development, Patient Services, Inc.
Mike Ellis, Corporate VP, Specialty Pharmacy & Infusion,
Walgreens
Kelley D. Simpson, MBA, Senior Partner, Oncology Solutions, LLC
Surya Singh M.D., Corporate Vice-President, Head of Medical
Benefit Management, CVS Caremark
An oncology system of care requires coordination among
all oncology stakeholders. Some oncology groups are
interested in clinically integrating and aligning with a local
hospital for market positioning and capital access purposes. This session will present a case study of a hospital
affiliation transaction in which an oncology group desires
to remain independent, but to align with a local hospital
to position for future success. We will explore, among
other things:
Burt Zweigenhaft, Vice Chairman, Onco360 Oncology Pharmacy
• The planning process for the transaction
• Transaction structural options, such as
Professional Service, Management and
Co-Management arrangements
• Financial modeling and assessing transaction
feasibility
• Applicable business and regulatory
considerations
• Converting to hospital licensed services
and qualifying sites for 340B pricing
• Valuation considerations
• Key deal-maker/breaker terms
What will be the impacts to and responses from the
drug sector with regard to health reform; new drug
breakthroughs in the pipeline; migration to orals;
conversion of many drugs from brand to generic;
alternate site-of-care? What effect on the business
model for oncology providers, manufacturers, pharmacy
benefits management and specialty pharmacy. In this
session, panelists will address and shed light on these
paradigms and changing dynamics.
www.CancerBusinessSummit.com
What will the drug supply chain look like in the
oncology system of the future? What are managed care
payers thinking? What is the future of drug buy and bill?
Will there be formularies? Will drug co-payments and
coinsurance deductibles present greater burdens on
patients? What are Limited Distribution Networks
going to look like in future?
21
Choose Your Own Path
Challenges create opportunities to adapt, differentiate, and thrive.
Challenges
Opportunities
Cost and complexity of cancer
care is accelerating
Give your physicians tools to stay
abreast of rapid changes
Payers and referring physicians
are demanding value
Measure and prove your value
New reimbursement models
require risk or gain share
Reduce hospitalizations and futile care
Predict your costs and participate in
new reimbursement models
Choose to thrive with Via Pathways
Via Oncology
5750 Centre Avenue, Suite 500
Pittsburgh, PA 15206
Phone: 412.204-1050
www.viaoncology.com
FRIDAY, NOVEMBER 7, 2014 (Continued)
Breakout Sessions
11:30 a.m. - 12:30 p.m.
Track A
Track B
INTERNATIONAL BALLROOM (SECOND LEVEL)
GOLD ROOM (SECOND LEVEL)
Oncologist-Hospital Alignment: Implementing
the Relationship
Showcase of ASCO-JOP Case Studies
Ronald Barkley, M.S., J.D., Cancer Center Business
Development Group
Teri U. Guidi, MBA, FAAMA, President and Chief Executive Officer,
Oncology Management Consulting Group
Erich Mounce, Chief Executive Officer, The West Clinic
In the preceding session, the elements of framing and
transacting an oncologist alignment were examined in
the context of a case study. Applying the working
assumptions of the same case study, panelists in this
session will describe the process and the elements of
implementing the newly transacted relationship.
How do you go about integrating services and actually
making the agreed upon terms of the relationship
operational? Topics to be explored in this session
will include:
This year the Cancer Center Business Summit and the
Journal of Oncology Practice® (JOP) solicited business
case studies that highlight problems that oncology
practices face and the strategies that practices used to
address them with a focus on tangible issues related to
oncology care delivery and/or pertinent to the mechanics
and business of oncology practice. Three case studies have
been selected from the submissions for presentation in this
session. Come to this session and learn from your peers.
• Integrating an Ambulatory Oncology Pharmacy
Specialist into a Community Medical Oncology Practice
• Implementation of Pharmacy Service Using
Computer and Audio-Visual Technology in
22 Oncology Clinics
• Integrating Efficiency and Effectiveness through the
Use of Strategic Analytics
• Governance & control
• Program strategy & vision
• Management, staffing, provider credentialing
• Facilities requirements
• IT/EMR interoperability
• Drug procurement and drug management
• Revenue cycle, billing & collections
• Research, clinical trials program continuity
• Roll-out communications plan
12:30 p.m.
2014 Summit Adjourns
www.CancerBusinessSummit.com
23
QUANTIFY, COMPARE, EMPOWER
YOUR ONCOLOGY PRACTICE
LEUKEMIA
NHL
MM
MDS
GYNE
PROSTATE
LUNG
BREAST
OTHE
R
HEAD & NECK
NEOPLASM
PANCREATIC
BLADDER
MELANOMA
OTHER
COLORECTAL
LOCAL
30
COMPETITIVE
BUSINESS DSO
OVARIAN
25
20
OTHER/
UNKNOWN
PAYER
COST
15
wRVU 2011
10
5
0
25TH
50TH
AVERAGE
75TH
PRESSURES IMPACTING
BUSINESS DECISIONS
ONCOLOGY METRICS® provides informational products and services for
the oncology community to promote and measure quantitative improvement
in oncology clinical and business practices.
ONCOLOGY CIRCLETM is a data sharing collaborative of best-in-class
oncology practices, dedicated to clinical and operational excellence through
the scientific collection and use of data.
www.OncoMet.com • email: [email protected]
2014 DISTINGUISHED FACULTY
*Conflict of interest disclosure information for faculty members is posted on the Summit’s website, www.cancerbusinesssummit.com.
Edward Abrahams, Ph.D.
President
Personalized Medicine Coalition
Washington, DC
John V. Cox, D.O., MBA, FASCO
Texas Oncology, PA
Editor, Journal of Oncology Practice
Dallas, Texas
Melissa Grimes Ayles
Director of Partner Relations
& Business Development
Patient Services, Inc.
Midlothian, Virginia
Alan H. Einhorn, J.D.
Of Counsel
Foley & Lardner LLP
Boston, Massachusetts
Ronald Barkley, M.S., J.D.
President
Cancer Center Business Development Group
Bedford, New Hampshire
Thomas R. Barr, MBA
General Manager
Oncology Metrics®, a division of
Flatiron Health, Inc.
Jacksonville, Florida
Michael L. Blau, J.D.
Chair, Industry Teams
Partner
Foley & Lardner LLP
Boston, Massachusetts
Diane Blum, MSW, FASCO
Former Chief Executive Officer
Lymphoma Research Foundation
New York, New York
Linda D. Bosserman, M.D., FACP
Assistant Clinical Professor
City of Hope
Duarte, California
Lindsay Conway, MSEd
Practice Manager, Oncology Roundtable
The Advisory Board Company
Washington, DC
Gena Cook
Co-Founder and Chief Executive Officer
Navigating Cancer
Seattle, Washington
Christine Cournoyer
Chief Executive Officer
N-of-One
Lexington, Massachusetts
Mike Ellis
Corporate VP, Specialty Pharmacy & Infusion
Walgreens
Deerfield, Illinois
Elizabeth S. Elson, J.D.
Of Counsel
Foley & Lardner LLP
Los Angeles, California
Matthew Farber, MA
Director, Provider Economics and Public Policy
Association of Community Cancer Centers
Washington D.C.
Brian S. Gorin
Managing Principal
Analysis Group, Inc.
Boston, Massachusetts
Teri U. Guidi, MBA, FAAMA
President and Chief Executive Officer
Oncology Management Consulting Group
Pipersville, Pennsylvania
John Hennessy, MBA, CMPE
Vice President, Operations
Sarah Cannon Cancer Services
Kansas City, Missouri
Scott Herbert, M.D.
President
New Mexico Cancer Care
Santa Fe, New Mexico
Daryl Johnson, MAcc, CVA
Managing Partner
HealthCare Appraisers, Inc.
Delray Beach, Florida
Paul H. Keckley, Ph.D.
Managing Director
Navigant Center for Healthcare Research &
Policy Analysis
Chicago, Illinois
www.CancerBusinessSummit.com
Ira M. Klein, M.D., MBA, FACP
National Medical Director,
Clinical Thought Leadership
Office of the Chief Medical Officer, Aetna
Hartford, Connecticut
Michael Kolodziej, M.D.
National Medical Director Oncology Solutions
Aetna
Albany, New York
Tony Kouba, MS, MHA
Vice President
INTEGRATED Healthcare Strategies
Los Angeles, California
Peter Kuhn, Ph.D.
Dean’s Professor of Biological Sciences
USC Dornsife
Los Angeles, California
Allen S. Lichter, M.D., FASCO
Chief Executive Officer
American Society of Clinical Oncology®
Alexandria, Virginia
W. James Lloyd, CPA/ABV, ASA, CFE
Principal
Pershing Yoakley & Associates
Knoxville, Tennessee
Kathleen G. Lokay
President and Chief Executive Officer
Via Oncology
Pittsburgh, Pennsylvania
Gary H. Lyman, M.D., MPH
Co-Director
Fred Hutchison Institute for Cancer Outcomes
Research
Seattle, Washington
Constantine A. Mantz, M.D.
Chief Medical Officer
21st Century Oncology
Lehigh Acres, Florida
Maurie Markman, M.D.
Senior Vice President for Clinical Affairs
Cancer Treatment Centers of America
Philadelphia, Pennsylvania
25
MolecularHealth:
putting the person
in personalized medicine.
MolecularHealth’s proprietary computational system transforms molecular data into
clinically actionable information to inform the most efficient and safest cancer treatment
options for each individual cancer patient. Our TreatmentMAP™ solution provides
a best in class software and diagnostic platform for molecular interpretation, drug safety
and unique treatment decision support for oncologists and each of their cancer patients.
UNITED STATES
Next Generation Sequencing
Laboratory / US Headquarters
2700 Technology Forest Blvd.
The Woodlands, TX 77381
T 832-299-3000
EUROPE
MolecularHealth Inc.
275 Grove Street
Suite 2-400
Newton, MA 02466
T 617-901-5939
MolecularHealth GmbH /
Global Headquarters
Belfortstraβe 2
69115 Heidelberg
Germany
T +49 6221 43851-0
2014 DISTINGUISHED FACULTY (Continued)
*Conflict of interest disclosure information for faculty members is posted on the Summit’s website, www.cancerbusinesssummit.com.
Catherine A. McCarty, Ph.D., MPH
Principal Research Scientist
Essentia Health
Duluth, Minnesota
Barry Russo, MBA
Chief Executive Officer
The Center for Cancer and Blood Disorders
Ft. Worth, Texas
Larry Strieff, M.D.
Specialty Medical Director
Hill Physicians Medical Group
San Ramon, California
Erich Mounce, MHA
Chief Executive Officer
The West Clinic
Memphis, Tennessee
Marc Samuels, J.D., M.P.H.
Chief Executive Officer
ADVI
Washington, DC
Amy Supraner, R. Ph.
Strategic Planning Manager
National Network Contracting Strategies
Aetna
Orlando, Florida
Therese Mulvey, M.D.
Physician-in-Chief/Medical Oncology
SouthCoast Health System
New Bedford, Massachusetts
Richard L. Schilsky, M.D., FACP, FASCO
Chief Medical Officer
American Society of Clinical Oncology®
Alexandria, Virginia
Khanh Nguyen, Pharm.D.
Director, Clinical Support Hill Physicians
Medical Group
San Ramon, California
Eric Schuur, Ph.D.
Principal, VMWA LLC
Associate, the Jon Block Group
Palo Alto, California
Gitesh Patel
Chief Executive Officer
Sargas Pharmaceutical Adherence and
Compliance (SPAC) International
Bakersfield, California
Kelley D. Simpson, MBA
Senior Partner
Oncology Solutions, LLC
Decatur, Georgia
Kavita Patel, M.D., MS
Fellow and Managing Director for Clinical
Transformation & Delivery
Engelberg Center for Health Care Reform
The Brookings Institution
Washington, DC
Jeff Patton, M.D.
Chief Executive Officer Tennessee Oncology
Chief Medical Officer Rain Tree Oncology
Services
Nashville, Tennessee
Denise K. Pierce
President and Chief Executive Officer
DK Pierce & Associates, Inc.
Zionsville, Indiana
Bruce S. Pyenson, FSA, MAAA
Principal and Consulting Actuary
Milliman
New York, New York
Julie Rosen, MMHS
Executive Director
Schwartz Center for Compassionate Healthcare
Boston, Massachusetts
Jeff Sinaiko
Founding Principal/Special Advisor
Altegra Health
Los Angeles, California
Surya Singh, M.D.
Corporate Vice-President, Head of Medical
Benefit Management
CVS Caremark
Lincoln, Rhode Island
Maria Sipala
Director, Strategic Planning
National Network Contracting Strategies
Aetna
Hartford, Connecticut
Rebecca Sutphen, M.D., FACMG
President & Chief Medical Officer
InformedDNA
St. Petersburg, Florida
Timothy J. Thompson
Chief Executive Officer
Intervention Insights
Cambridge, Massachusetts
Dan Todd
Former Health Policy Advisor
Senate Finance Committee
Washington, DC
Elaine L. Towle, CMPE
Director, Consulting Services
Oncology Metrics®, a division of
Flatiron Health, Inc.
Chester, New Hampshire
Robin T. Zon, M.D., FACP
Michiana Hematology Oncology &
Clinical Practice Committee
American Society of Clinical Oncology®
South Bend, Indiana
Burt Zweigenhaft
Vice Chairman
Onco360 Oncology Pharmacy
New York, New York
Mark L. Sobczak, M.D.
Chief Network Officer and Senior Vice
President
Fox Chase Cancer Center
Philadelphia, Pennsylvania
John Steiner, Esq.
Chief Compliance & Privacy Officer &
Associate General Counsel
Cancer Treatment Centers of America
Schaumburg, Illinois
www.CancerBusinessSummit.com
27
As healthcare costs continue to rise and
the covered population continues to grow,
the US must confront a stark reality.
Federal and state governments are joining payers in shifting toward pay for value
concepts. The ADVI team looks at the healthcare system from the perspective
of the future; we consider how the system will evolve. We help our clients to
identify the point in time when today becomes tomorrow. We are prepared for
the opportunities that lie ahead and invite you to have a conversation with us.
www.advi.com or [email protected]
Financial Help for Cancer Patients
Offering Resources to Help Obtain Financial and
Reimbursement Assistance for Qualified Uninsured,
Underinsured, and Insured Patients
How We Can Help
• Insurance Information
• Patient Assistance Program
• Reimbursement Assistance for Eligible Lilly Oncology
Products for an Approved Diagnosis
• Denied Claim Appeals Information
PatientOne program specialists are available Monday-Friday, 9 am-7 pm ET. Call 1-866-4PatOne (1-866472-8663) and let us know what we can do to help. Visit www.LillyPatientOne.com for more information.
ON92894 © Lilly USA, LLC 2014. ALL RIGHTS RESERVED.
For HR+, early-stage invasive breast cancer
Confidence begins with a highly
accurate risk assessment
© 2014 NanoString Technologies, Inc. All rights reserved. NanoString, the NanoString
Technologies logo, Prosigna and the Prosigna logo are trademarks and/or registered
trademarks of NanoString Technologies, Inc. in various jurisdictions.
Dedicated to helping you and your oncology
program achieve and sustain peak
performance…OMC Group’s experts deliver!
OMC GROUP…
Outstanding experts, Outstanding results!
• Financial and Market Analyses
• New Center Development
• Hospital/Physician Integration
• Strategic Planning
• Operational Assessments
• Revenue Cycle Reviews
• Implementation and
Interim Leadership
• Performance and
Financial Benchmarking
Oncology Management Consulting Group
215-766-1280 • www.oncologymgmt.com • [email protected]
INVENTIVE SOLUTIONS ● SUCCESSFUL OUTCOMES
ONCOLOGY RESOURCE CONSULTANTS, INC.
A CONSULTING FIRM WORKING EXCLUSIVELY IN THE FIELD OF ONCOLOGY
Oncology Resource Consultants, Inc. collaborates with health care providers and organizations across the oncology spectrum.
For the past twenty five years, ORC has provided value to clients with varied perspectives relating to the provision of cancer care.
ORC’s consulting services include:
•
•
•
•
•
Cancer program and oncology practice strategic planning;
Cancer center programmatic, financial and operational
feasibility studies;
Facilitation of planning and structuring collaborative
cancer services provision for hospitals, physicians and
other third parties;
Detailed financial analysis and projections for hospitals,
physicians and other providers;
Space planning for oncology facilities;
CONTACT US: (301) 424-6000 | WWW.ONCOLOGYRESOURCE.COM
•
•
•
•
Operational assessments for specific cancer services
correlating with place of service provision;
Cancer care coordination planning for the cancer care
continuum;
Coding and compliance assessments and audits for
hospitals, physicians and their respective legal counsel;
and
Financial assessments for oncology services.
104 SOUTH WASHINGTON STREET | ROCKVILLE, MD 20850
Cancer Isn’t Selective
BUT YOU CAN BE
Community oncology practices give special care to cancer
patients and deserve Exceptional service!
Exceeding customer expectations has been
our focus since 1978.
Let Oncology Supply
Be Your Distributor Of
Choice
800-633-7555
oncologysupply.com
Benjamin Franklin once said,
“Diligence is the mother of good luck.”
Valuing healthcare organizations is a complex undertaking
requiring substantial industry knowledge, solid technical skills,
practical experience, and diligence.
PYA’s valuation professionals have a deep understanding of the
complex environment in which healthcare businesses operate.
Our valuation team also has the technical expertise and practical
hands-on experience needed to deliver valuation opinions and advice
that clients can rely upon for making sound business decisions.
But you need
But you need
more
than luck.
more than
luck.
Let’s get to work.
TM
We call it Vision Beyond the Numbers, and it can work for you.
Benjamin Franklin once said,
“Diligence is the mother of good luck.”
VISION
»
Valuing healthcare organizations is a complex undertaking requiring
substantial industry knowledge, solid technical skills, practical
experience,
and diligence.
regulatory
compliance|
mergers and acquisitions | joint ventures
| transaction planning
financial
reporting|have
taxacompliance
| disputes
valuation professionals
deep understanding
of the and litigation
PYA’s
complex environment in which healthcare businesses operate. Our
valuation team also has the technical expertise and practical
hands-on experience needed to deliver valuation opinions and advice
that clients can rely upon for making sound business decisions.
www.pyapc.com
Castle Connolly
Helping Patients Find the Best Healthcare
America’s premier resource for
finding Top Doctors, Castle
Connolly helps patients identify
high quality doctors based on
research and thorough
selection processes.
With a network of
over 40,000 of the
nation’s top doctors
and specialists, Castle Connolly
has been delivering leadership,
and innovation to the industry
for more than 20 years.
Castle Connolly Private Health
Partners provides step-by-step,
expert assistance to leading
physicians as they transform
their practices to a membershipbased model.
In addition to ongoing
marketing and promotion
assistance, Castle Connolly PHP
provides a health coaching
program that is shown to be
highly effective in motivating
patient behavior change.
For more information visit
www.castleconnolly.com • www.ccphp.net
Cance r i s s ca r y.
Devel opi n g you r
bu s i nes s s t rategy shou l d n’t b e.
Effective diagnosis and treatment of cancer requires a
TESTS
SEQUENCING
ANALYSIS
INTERPRETATION
WE'RE MAKING GENOMICS CLINICALLY ACTIONABLE
FOR ANY PHYSICIAN ANYWHERE.
Appistry CloudDxSM orchestrates all of the services
necessary to deliver genomics tests, so that physicians can
select the right test for the right patient at the right time to
impact diagnosis and treatment.
Start practicing genomically
enhanced medicine.
http://appistry.com/gem
See us at the Cancer Center Business Summit
in Chicago
November 6-7, 2014.
TRUSTWORTHY.
AUTHORITATIVE.
RELEVANT.
unique mix of specialties and services that spans several
departments/divisions and often multiple entities.
ECG has a proven track record of partnering with
community- and AMC-based cancer centers to achieve
tangible results that engage physicians, further
integrate the care delivery model, and improve
the financial performance of your program.
ASCOPOST.COM
800.729.7635
ecgmc.com/cancer
PHYSICIAN ALIGNMENT + LABOR STRATEGIES +
ENGAGEMENT MEASUREMENT + GOVERNANCE
DEVELOPMENT + COMPENSATION GUIDANCE
+ EXECUTIVE ADVISEMENT + LEADERSHIP
PLACEMENT + STRATEGIC CONSULTATION
www.INTEGRATEDHealthcareStrategies.com
816.743.4641
Aligning Payers and Providers
Through Clinical Data and Technology
Leading health plans and
providers turn to us for evidence-based,
affordable patient care.
New Century Health sets the new standard in technology
enabled oncology care:
• Leading-edge clinical decision support system in
use by over 4,000 oncologists in over 30 states
• Advanced informatics and quality benchmarking
powers population health management
• Comprehensive oncology quality management
program that integrates and aligns care delivery
• Experience working with risk-based clients like
ACOs, MSOs and Medicare Advantage Plans
www.newcenturyhealth.com
JOURNAL OF
ONCOLOGY
PRACTICE
The Authoritative Resource for Oncology Practices
CCBS Attendees—Improve the Business Side of Your
Practice By Reading JOP
Volume
9, Issue
1
JOURN
A
ONCOL L OF
PRACTI OGY
Journal of Oncology Practice (JOP) is ASCO’s bimonthly forum that
demonstrates how to improve the quality and efficiency of cancer care while
reducing costs and improving patient satisfaction.
The Autho
for Oncol ritative Resource
ogy Pra
ctices
January
2013
CE
By subscribing to JOP you’ll benefit from:
Special
Series: Whe
re Does
Accountabl
Oncolog
e Care?
y Fit in the
Ronald Bark
Scheme
ley
Special
of
Series: Onc
ology Prof
Model for
essiona
Hospita
l Services
l Affiliati
on That
Agreem
Blau
Preserve
ents: A
s Private
Practice
Improving
Work-Up
of the Abn
Organiz
ed Assessm
ormal Mam
ent: Res
mogram
Screenin
ults From
Through
g Program
the Ontario
May Lynn
Quan et all
Breast
Update
on Direct-to
-Consum
Stacy W.
Gray et al
er Marketi
ng in Onc
ology
Palliativ
e Care: A
Lifeline
Rebecca Anne
to Quality
Kirch et al
of Life
• Access to current and archival issues
Michael L.
• ASCO peer-reviewed Clinical Guideline summaries
• Podcasts of interviews with authors offering exclusive insights that expand
on the utility of their articles
jop.ascop
ubs.o
rg
• Early-Release Articles providing key practice management information
available weeks before print publication
• Convenient JOP iPad and iPhone apps offering an enhanced reading
experience while on the go
• Access from mobile devices allowing for easy viewing of
jop.ascopubs.org available via an optimized web site for smartphones
Exclusively for CCBS Attendees
Look for Your Complimentary Copy of
JOP In Your Registration Packet
• Centralized job search through the online career center
Key JOP Features:
• Published for all members of the practice—administrators, physicians, and nurses
• Focuses on improving practice efficiency and quality of care
• Covers legal, financial, technology, and personnel issues
• Content is MEDLINE indexed and peer-reviewed
SUBSCRIBE NOW
Log on to http://JOP.ascopubs.org/subscriptions
or call 1-888-273-3508.
Please refer to your conference code ECADE01
BUSINESS CASE STUDIES
Integrating Efficiency and Effectiveness
Through the Use of Strategic Analytics
By Steven Cheng, Caryn Steakley, and David Dilts
Dilts + Partners, Plano, TX; and National Cancer
Institute, Bethesda, MD
Conducting Retrospective Longitudinal
Data Analyses in ICD-9-CM in the Age of
ICD-10-CM
By Ardaman Shergill, Parvaneh Dorestani, Andrew D.
Boyd, and Neeta K. Venepalli
Implementation of Outpatient Pharmacy
Chairside Medication Dispensing in
Collaboration With Several Ambulatory
Oncology Clinics
By Brad Given, Ashley Feldt, and Jennifer Godden
Vince Lombardi Cancer Clinics, Aurora Cancer Care,
Aurora Health Care, Milwaukee, WI
Community Cancer Centers: The Struggle
With Billing and Coding Compliance
By June Brown
University of Illinois at Chicago; and University of Illinois
Hospital and Health Science System, Chicago, IL
University of California Davis Health System Cancer Care
Network, Davis, CA
Integrating an Ambulatory Oncology
Pharmacy Specialist Into a Community
Medical Oncology Practice
Stereotactic Radiosurgery Treatment
Delivery Time Span: Case Study
By Wendy J. Smith, Kate D. Jeffers, Johnathan Romeo,
and Robert J. Hoyer
New Jersey CyberKnife, J. Phillip Citta Regional Cancer
Center, Toms River, NJ
Colorado Health Medical Group Hematology and Oncology,
Memorial Hospital; and University of Colorado Health,
Colorado Springs, CO
Reducing the Financial Impact of Cancer
Care for Patients
By Jacob C. Frick, Brad Zimmerman, and Stacy Spitler
Aurora Cancer Care of Aurora Health Care Metro,
Milwaukee, WI
By Debbie Moriarty
Implementation of Pharmacy Service
Using Computer and Audiovisual
Technology in 22 Oncology Clinics
By Ashley Feldt and Arlene Iglar
Vince Lombardi Cancer Clinics, Aurora Cancer Care,
Aurora Health Care, Milwaukee, WI
Delivering innovative
consulting solutions to
transform cancer care
Hospital-Physician
Alignment Strategies
TAKE HOLD OF YOUR INDUSTRY WITH...
Clinical Program
Development
OBR’s 100% FREE ONCOLOGY FOCUSED E-NEWS SERVICE
Cancer Program Planning
and Development
Oncology Revenue
Cycle and Operations
Cancer Facility and
Technology Planning
Get timely, comprehensive
coverage of oncology news
and events delivered right
to your inbox. Every day, we
filter and prioritize oncology
news stories from all major
media outlets so you don’t
have to.
REGISTER TODAY AT
404.836.2000
www.oncologysolutions.com
The Personalized Medicine Coalition (PMC), representing innovators, scientists, patients, providers and
payers, promotes the understanding and adoption
of personalized medicine concepts, services and
products to benefit patients and the health system.
The Coalition’s mission is to educate policymakers
and the public about the power and potential of
individualized health care and raise the profile of
personalized medicine so that both patients and
the health system will benefit from improved clinical
care and increased overall value.
personalizedmedicinecoalition.org
202.589.1770
1710 Rhode Island Ave, NW · Suite 700
Washington, DC 20036
OBRONCOLOGY.COM
focused on building and sustaining strong
patient-caregiver relationships
Compassion is
good medicine.

www.theschwartzcenter.org
B2 Lev
Emergency Exit
Regal
Room
Se
Exit
rvi
ce
lP
ar
lev
s
ria
tor
Fairmont Chicago, Millennium Park
pe
cE
va
Im
bli
Ele
Pu
at
Pre-Function
ors
Royal
Room
Escalators to
Concourse and Lobby
Emergency Exit
lor
Intermediate Columbus Drive
B2 level
Freight
Elevator
Freight
Elevator
Exibitors Dock
Freight
Elevator
Emergency
Exit
Emergency
Exit
Freight
Elevator
Freight
Elevator
Emergency
Exit
Pantry
Gold
Room
International
Ballroom
Pantry
Gold Room
International Ballroom
nt
Emergency
Exit
lev
at
k
es
ll D
aria bar
lobby level
Cuvee Room
Front Office
Foyer
Kosher
Kitchen Crystal Room
Kosher
Kitchen
Front Office
Foyer
Pr
e-
Fu
sk
Se
rvi
Concierge
k
es
ll D
k
at
ors
Be
es
ll D
To International
Ballroom Level
Be
E
Lo scal
we at
r L ors
ev to
els
s
lev
Pre-Function
Room
Ma
in
Ma
En
in
tra
En
nc
e
tra
nc
e
Chancellor
Room
Chancellor
Room
Diplomat
cE
lev
s
tor
cE
tor
va
bli
bli
va
Ele
Pu
Ele
ce
Emergency
Exit
Emergency Exit
ce
rvi
Pu
Emergency
Exit
Your Expert Oncology Resource
Emergency Exit
Se
Room
Eno Wine Room
n
n
De
sk
tio
De
nc
tio
Fu
nc
e-
nt
nt
Pantry
Kitchen
Es
ca
to lato
All rs
Le Do
ve wn
ls
Pr
Es
ca
to lato
All rs
Le Do
ve wn
lsPantry
Fro
Fro
Emergency
Exit
Crystal Room
Telephones
Telephones
Telephones
Telephones
Se
rvi
at
Revenue Cycle Inc. delivers customized, leading-edge strategies
and
services. Whether
you’re a private practice, freestanding
Regent
Regent
Pre-Function
Diplomat
Room
Room or a hospital-based healthcare provider, our team is
Room
cancer center
able to offer an array of services customized to meet your needs.
ors
tor
lev
at
ors
s
ors
aria Entrance
va
at
lobby level
Ele
lev
aria bar
cE
Porte-cochère
aria bar
aria Entrance
ce
eE
bli
Porte-cochère
Emergency
Exit
Emergency
Exit
Rouge
Pu
Be
e
nc
tra
En
ors
State Room
second level
second level
Storage
Cuvee Room
aria restaurant
cE
s
bli
tor
Pre-Function Ambassador
State RoomPre-Function
Room
Ambassador
Room
Pu
ors
va
s
at
Ele
tor
lev
ce
va
cE
ors
To International
Ballroom Level
rvi
Ele
at
Emergency
Exit
Se
ce
Freight
Elevator
Storage
Concierge
ls
rvi
bli
s
lev
Intermediate Columbus Drive
Intermediate Columbus Drive
To International
Ballroom Level
Pre-Function
Eno Wine Room
Emergency
Exit
Emergency Exit
B2 level
Eno Wine
Private
Dining Room
ve
Audiovisual
Booth
Se
Pu
tor
s
cE
va
tor
Royal
Room
Royal
to
RoomEscalators
Concourse and Lobby
ri
bli
Ele
va
Pu
Pre-Function
at
al
Escalators
Pa to
rlo
Concourse
r and Lobby
Emergency Exit
Freight
Elevator
ce
Ele
ors
lev
ls
Emergency
Exit
Pantry
rvi
ce
at
cE
Regal
Room
Regal
Room
rvi
lev
bli
ve
E
St scal
air at
s t ors
o L to
ob Al
by l L
e
Pre-Function
Se
Se
eE
pe
E
St scal
air at
s t ors
o L to
ob Al
by l L
e
Pantry
Pu
Im
Imperial Office
Telephones
Audiovisual
Booth
in
Emergency Exit
Storage
Imperial Office
Embassy
Room
Embassy
Room
Ma
Auto
Lobby
Storage
aria restaurant
B2 Level Entrance
Cashier
Kitchen
Emergency
Exit
Private
Dining
Room
Telephones
aria Entrance
Telephones
Concierge
Emergency
Exit
Telephones
E
Lo scal
we at
r L ors
ev to
els
Emergency
Exit
sk
Imperial Ballroom
De
Kitchen
Pantry
Imperial
Ballroom
ors
Pre-Function
we at
r L ors
ev to
els
Front Office
Foyer
Telephones
Exit
hen
Rouge
Fro
Intermediate Lake Street
Cuvee Room
Garage Entrance
Emergency
Exit
cy Exit
Storage
Emergency Exit and
Ballroom Service
xit and
ervice
Porte-cochère
Third level
Third level
Medical and Radiation Oncology Services
•
•
•
•
•
•
•
•
•
•
•
•
Billing, Coding & Compliance Reviews
Training & Education
Electronic Medical Record Implementation
Process Review & Development
Client Resource Center
Remote Solutions
Front Office & Back Office Process Review
Revenue Enhancement
Regulatory Summation Updates
Proforma Creation
Sales Team/Customer Education & Support
New Technology Assessment
To speak to one of our experts, call 512.583.2000.
Or visit our website at www.revenuecycleinc.com.
NOTES
www.CancerBusinessSummit.com
NOTES
www.CancerBusinessSummit.com
39
THE 2014 CANCER CENTER BUSINESS SUMMIT HAS BEEN
BROUGHT TO YOU BY THE FOLLOWING ORGANIZATIONS.
Foley & Lardner LLP is a national law firm providing comprehensive legal services for
innovative enterprises in the health care, pharmaceutical, biotechnology and biomedical
sectors. Our health care attorneys provide counsel on financial transactions, mergers,
acquisitions, affiliations, joint ventures, regulatory and government compliance, and
business operations. With offices throughout the United States and the backing of
Foley’s Health Care Industry Team, named “Law Firm of the Year — Health Care Law”
for the third consecutive year by U.S. News – Best Lawyers®. Foley is well-positioned
to serve the wide-ranging needs of cancer care providers and other health care
organizations across the country.
Altos Solutions, Inc., a division of Flatiron Health provides secure web-based oncology-specific applications; focusing on intuitive electronic medical records, practice management with integrated medical billing, real-time comparative analytics, and patient
and provider portals. Altos is the first company in the US to offer oncology practices
an oncology-specific EMR application combined with services to collect, benchmark,
and analyze the data contained in these records. OncoEMR®, 2014 edition certified,
is used by over 1,300 oncologists and is the answer for all oncology practices, whether
solo practitioner oncologist, multi-location cancer centers, or hospital-based ambulatory
cancer centers. Altos Solutions is headquartered in Silicon Valley, CA. To learn more,
call (888) 662-6367 or 888-OncoEMR, or visit http://AltosSolutions.com.
Cancer Center Business Development Group (CCBD Group) provides professional
business advisory services to stakeholders in the delivery of cancer care…transitioning
oncology providers to the value-based paradigm. Expertise in oncology group practice
mergers, growth initiatives and strategic partnering options; oncologist-hospital
economic alignment and clinical integration; alternate payment methodologies:
CMMI-Oncology Care Model program design, value-based fee structures, shared
savings, bundled pricing. www.ccbdgroup.com.
Founded in 1964, the American Society of Clinical Oncology (ASCO) is the world’s
leading professional organization representing physicians who care for people with
cancer. With more than 35,000 members, ASCO is committed to improving cancer
care through scientific meetings, educational programs and peer-reviewed journals.
ASCO is supported by its affiliate organization, the Conquer Cancer Foundation, which
funds ground-breaking research and programs that make a tangible difference in the
lives of people with cancer. For ASCO information and resources, visit www.asco.org.
Patient-oriented cancer information is available at www.cancer.net.
www.CancerBusinessSummit.com
41
www.CancerBusinessSummit.com